We are a pharmaceutical company specialized in the comercialization of exclusive medicines, innovative and orphan drugs.

We develop and implement market strategies to guarantee access to all patients to the most effective therapies and best treatments.

Mission & Vision

We believe in the fundamental values ​​of integrity, ethics and social commitment.

We want to be recognized as an international partner, attentive to the needs of patients and health professionals, completely dedicated to proposing effective solutions through innovation, quality and competence.

We offer high standards of services at all times that improve patients’ lives through a large portfolio of low-cost medicines, with particular attention to rare diseases.

Who we are

We are a young and dynamic pharmaceutical company which, through the coordination of an international team of highly qualified, competent and motivated professionals and partners, captures the full potential and evolution of the market to successfully commercialize medicinal specialties, innovative drugs and orphan drugs.

we manage our business in full transparency, fairness and loyalty to customers, suppliers and healthcare professionals.

we deeply know the market and we use our experience for the success of the products.

we have excellent cross-functional skills in commercial operations, medical affairs and market access and a solid infrastructure and local presence with a patient-centered approach.

Chi siamo

Therapeutic areas

Avas Pharmaceuticals is focused on the commercialization of a wide portfolio of specialties, niche hospital and orphan products to respond to unmet medical needs.

qode-eliptic-slider

Cardiovascular

– Aldactone ®
– Inibace ®
– Sotalex ®

qode-eliptic-slider

Antiinfective

– Citovirax ®
– Cymevene ®
– Fungizone ®
– Lariam ®

qode-eliptic-slider

Antineoplastic

– Everolimus ®
– Vepesid ®

qode-eliptic-slider

Central Nervous system

– Roipnol ®
– Twice ®

qode-eliptic-slider

Other areas

– Anexate ®
– Kryptocur ®
– Visudyne ®

12
K

deliveries

4
MIO

units sold

21

drugs in portfolio

€ 13.1
MIO

revenue

*2019 data

We create customised solutions effectively and with a target of excellence.

We provide direct, transparent and constant communication and reports.

We create long-term and trusting relationships with our partners an clients.

Contacts

For any kind of information you can contact us through the web form.

AVAS PHARMACEUTICALS S.R.L.

Milan - Italy

ADMINISTRATION
administration@avaspharma.com

BUSINESS DEVELOPMENT&
STRATEGIC ALLIANCES
bd@avaspharma.com

MEDICAL INFORMATIONS
medinfo@avaspharma.com

PHARMACOVIGILANCE
pv@avaspharma.com

PHONE
+39 02 47923811

FAX
(+39) 02 94755045

I consent to the processing of my personal data, pursuant to the General Regulation 2016/679 GDPR. Read the Privacy Policy.

Trasparenza e Pubblicità – LEGGE 124-2017

Ai sensi dell’art. 1 comma 125-bis, della Legge 04/08/2017 n. 124, in ottemperanza all’obbligo di trasparenza si segnala che la società è stata destinataria nel corso dell’esercizio sociale chiuso al 31/12/2020 di sovvenzioni, sussidi, vantaggi, contributi o aiuti pubblici in denaro o in natura, non aventi carattere generale, che vengono dettagliati nella tabella in allegato.

 

Inoltre la società ha ricevuto nel corso dell’esercizio sociale chiuso al 31/12/2020 Aiuti di Stato di cui all’art. 52 Legge n. 234/2012 oggetto di obbligo di pubblicazione nel Registro Nazionale Aiuti di Stato ed ivi indicato nella sezione trasparenza a cui si rinvia.